Tyler E. Miller
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Genetics top 2%
- Glioma Diagnosis and Treatment
Papers in
-
- Epigenetics and DNA Methylation 7
- Single-cell and spatial transcriptomics 4
-
- MicroRNA in disease regulation 6
- Cancer Genomics and Diagnostics 3
- Co-authors
- Jeremy N. Rich (12 shared papers)Samson T. Jacob (2 shared papers)Jharna Datta (2 shared papers)Sarmila Majumder (2 shared papers)Satavisha Roy (2 shared papers)Charles L. Shapiro (1 shared paper)Bhuvaneswari Ramaswamy (1 shared paper)Kalpana Ghoshal (1 shared paper)
- Journals
- Neuro-Oncology (3 papers)Cell (2 papers)Journal of Clinical Microbiology (1 paper)The Oncologist (1 paper)Neuro-Oncology Advances (1 paper)
- Partner nations
- United StatesGermanyChina
In The Last Decade
Tyler E. Miller
30 papers receiving 2.7k citations
Tyler E. Miller's Hit Papers
Peers
Comparison fields: 5 of 101
- Cancer Research 947
- Genetics 391
- Infectious Diseases 402
- Molecular Biology 1.5k
- Oncology 452
Countries citing papers authored by Tyler E. Miller
This map shows the geographic impact of Tyler E. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tyler E. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tyler E. Miller more than expected).
Fields of papers citing papers by Tyler E. Miller
This network shows the impact of papers produced by Tyler E. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tyler E. Miller. The network helps show where Tyler E. Miller may publish in the future.
Co-authors
The 25 scholars most cited alongside Tyler E. Miller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1 Hit paper breakdown → | 2008 | 654 |
| 2 | 2020 | 417 | |
| 3 | 2016 | 373 | |
| 4 | 2015 | 266 | |
| 5 | 2017 | 262 | |
| 6 | 2013 | 154 | |
| 7 | 2011 | 97 | |
| 8 | 2022 | 78 | |
| 9 | 2015 | 74 | |
| 10 | 2009 | 62 | |
| 11 | 2016 | 52 | |
| 12 | 2016 | 43 | |
| 13 | 2020 | 40 | |
| 14 | 2018 | 37 | |
| 15 | Programs, origins and immunomodulatory functions of myeloid cells in glioma Hit paper breakdown → | 2025 | 29 |
| 16 | 2018 | 29 | |
| 17 | 2022 | 19 | |
| 18 | 2013 | 17 | |
| 19 | 2020 | 12 | |
| 20 | 2014 | 12 |
About Tyler E. Miller
Tyler E. Miller is a scholar working on Molecular Biology, Cancer Research, Genetics, Infectious Diseases and Oncology, having authored 34 papers that have together received 2.8k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (7 papers), Glioma Diagnosis and Treatment (7 papers), MicroRNA in disease regulation (6 papers), Single-cell and spatial transcriptomics (4 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Neurogenesis and neuroplasticity mechanisms (3 papers), Cancer Genomics and Diagnostics (3 papers) and Cancer Cells and Metastasis (3 papers). The work is most often cited by research in Cancer Research (947 citations), Genetics (391 citations), Infectious Diseases (402 citations), Molecular Biology (1.5k citations) and Oncology (452 citations). Tyler E. Miller has collaborated with scholars based in United States, Germany and China. Frequent co-authors include Jeremy N. Rich, Samson T. Jacob, Jharna Datta, Sarmila Majumder, Satavisha Roy, Charles L. Shapiro, Bhuvaneswari Ramaswamy, Kalpana Ghoshal, David L. Schonberg and Stephen C. Mack. Their work appears in journals such as Neuro-Oncology, Cell, Journal of Clinical Microbiology, The Oncologist and Neuro-Oncology Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.